Synageva BioPharma
Discovering, developing, and delivering innovative medicines for people living with rare diseases of high unmet medical need.
Launch date
Employees
Market cap
-
Enterprise valuation
$8.4b (Public information from May 2015)
Lexington Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | Series B | |
$13.1m | Series D | ||
$10.1m | Series E | ||
$17.2m | Series E | ||
$30.0m | Series F | ||
$12.0m | Series F | ||
| N/A | $3.0m | Series F | |
$25.0m | Late VC | ||
| N/A | N/A | IPO | |
* | N/A | $179m | Post IPO Equity |
* | N/A | $308m | Post IPO Equity |
$8.4b Valuation: $8.4b | Acquisition | ||
| Total Funding | $110m | ||